Literature DB >> 24859332

GD1b-specific antibodies may bind to complex of GQ1b and GM1, causing ataxia.

Nobuhiro Yuki1, Yuki Fukami, Chiaki Yanaka, Saiko Koike, Koichi Hirata.   

Abstract

Monospecific IgG antibodies to GD1b ganglioside (GD1b-specific antibodies) have been found in patients with acute ataxic neuropathy and Guillain-Barré syndrome, but the association of the GD1b-specific antibodies with specific neurological conditions has yet to be established. We tested sera from more than 10,000 patients with various neurological disorders, and found six sera, which contained IgG antibodies to GD1b, but not to LM1, GM1, GM1b, GD1a, GalNAc-GD1a, GT1a, GT1b and GQ1b. All six patients who carried GD1b-specific antibodies presented with acute onset of ataxia and monophasic course of the illness, of whom five demonstrated cerebellar-like ataxia. Four patients had antecedent symptoms of upper respiratory tract infection. The six patients demonstrated areflexia, and four complained of distal numbness. All the six patients who had the GD1b-specific antibodies carried IgG antibodies to complex of GQ1b/GM1 and GT1a/GM1. GD1b-specific antibodies were significantly absorbed by GQ1b/GM1 and GT1a/GM1 and anti-GQ1b/GM1 and -GT1a/GM1 antibodies were absorbed by GD1b. In conclusion, the GD1b-specific antibodies, which recognizes GQ1b/GM1 or GT1a/GM1 complex, are associated with acute ataxia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24859332     DOI: 10.1007/s00415-014-7388-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  16 in total

1.  Ataxic form of Guillain-Barr syndrome associated with anti-GD1b IgG antibody.

Authors:  N Yuki; K Susuki; K Hirata
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-07       Impact factor: 10.154

Review 2.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

3.  Ataxic Guillain-Barré syndrome with anti-GQ1b antibody: relation to Miller Fisher syndrome.

Authors:  N Yuki; K Susuki; K Hirata
Journal:  Neurology       Date:  2000-05-09       Impact factor: 9.910

4.  Range of cross reactivity of anti-GM1 IgG antibody in Guillain-Barré syndrome.

Authors:  M Koga; M Tatsumoto; N Yuki; K Hirata
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-07       Impact factor: 10.154

5.  Ataxic Guillain-Barré syndrome and acute sensory ataxic neuropathy form a continuous spectrum.

Authors:  Masafumi Ito; Kenjiro Matsuno; Yasuhiko Sakumoto; Koichi Hirata; Nobuhiro Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-01-20       Impact factor: 10.154

6.  Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome.

Authors:  K Yako; S Kusunoki; I Kanazawa
Journal:  J Neurol Sci       Date:  1999-10-15       Impact factor: 3.181

Review 7.  Glycolipid antigens and autoantibodies in autoimmune neuropathies.

Authors:  Hugh J Willison; Carl S Goodyear
Journal:  Trends Immunol       Date:  2013-06-13       Impact factor: 16.687

8.  Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies.

Authors:  A Chiba; S Kusunoki; H Obata; R Machinami; I Kanazawa
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

9.  Clinical predictors of mechanical ventilation in Fisher/Guillain-Barré overlap syndrome.

Authors:  K Funakoshi; S Kuwabara; M Odaka; K Hirata; N Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-10-23       Impact factor: 10.154

10.  Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles.

Authors:  Jing-Xia Liu; Hugh J Willison; Fatima Pedrosa-Domellöf
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-28       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.